drugset / Trial / NCT00690677
Phase II Trial of LBH589 in Refractory Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effects of the study drug, LBH589, on patients with metastatic colorectal cancer that has continued to grow despite previous treatment.
Timeline
- Start
- 2008-06
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panobinostat | Small molecule | 30 mg | Oral |